
Functional Brands Inc.
93
Recent news highlights include Functional Brands' strategic acquisition plans, product launches, and financial results announcements, reflecting ongoing business activities and market engagement.
- Functional Brands Inc. signed a binding letter of intent to acquire the assets of BullionFX | Alchemy for $142.9 million, indicating strategic expansion efforts [N1].
- The company announced the launch of GLP-Squared Injection, expanding its product offerings in 2026 [N1].
- Functional Brands entered a strategic partnership with partnrup.ai to accelerate growth of its Tru2u.health digital health platform [N1].
- The company unveiled a new weight loss support bundle aimed at boosting digestion, metabolism, and muscle preservation [N1].
- Functional Brands announced a conversion price adjustment agreement for Series C Preferred Stock in May 2026 [N1].
Functional Brands Inc. is a nutraceutical supplement company focused on manufacturing and distributing a wide range of dietary supplements under the Kirkman brand, which serves special dietary needs including autism spectrum disorders. The company operates an FDA registered, cGMP certified manufacturing facility and distributes products in the US and internationally. It has expanded its business model to include a digital health platform, Tru2u.health, offering supplements and telehealth services. The company has undergone capital restructuring involving convertible preferred stock and has discontinued hemp-derived product lines. Its common stock was delisted from Nasdaq and now trades on OTC Markets. Financially, the company reported revenues of $1.6 million and a net loss in Q3 2026, with liquidity challenges indicated by a current ratio of 0.3 [S1][S2].
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Functional Brands Inc. operates in the nutraceutical supplement industry, manufacturing and distributing a broad range of supplements primarily through its Kirkman division. The company has expanded into digital health services with the Tru2u.health platform. It has discontinued hemp-related products and completed several capital restructuring transactions involving convertible preferred stock. As of September 30, 2026, the company reported revenues of approximately $1.6 million and a net loss of $714,455, with liquidity ratios indicating limited short-term liquidity. The company's common stock was delisted from Nasdaq and now trades on OTC Markets, which may affect liquidity and capital raising. Recent developments include strategic acquisitions and product launches [S1][S2][N1].
Functional Brands Inc. benefits from a diversified product portfolio under the Kirkman brand, addressing multiple health and wellness categories with a focus on special dietary needs. The company's FDA registered manufacturing and certifications for prenatal vitamins align with growing consumer demand for safe, transparent supplements. The launch of the Tru2u.health digital platform extends the company's reach into telehealth and recurring revenue models, potentially broadening consumer engagement. Strategic acquisitions and partnerships indicate active efforts to expand market presence and product offerings [S1][N1].
The company faces significant financial challenges, including a net loss and low liquidity ratios as of Q3 2026, which may constrain operational flexibility. The delisting from Nasdaq and trading on OTC Markets could reduce stock liquidity and investor interest, complicating capital raising efforts. The discontinuation of hemp-derived products may reduce revenue diversification. The convertible preferred stock structure with complex terms and dividend obligations may impose financial burdens. Market competition in the nutraceutical and digital health sectors is intense, and regulatory scrutiny remains a risk despite non-FDA approval status [S1][S2][Q0].
Functional Brands Inc.'s moat is anchored in its established Kirkman brand, which has a long history since 1949 serving special dietary needs with rigorously tested nutraceutical products. The company's FDA registered and cGMP certified manufacturing facility supports product quality and regulatory compliance. The Kirkman brand's extensive product portfolio across 95% of supplement subsegments and its global distribution network to over 35 countries provide broad market reach. Additionally, the company's unique positioning with certified prenatal vitamins aligned with FIGO standards and its expansion into digital health services via Tru2u.health contribute to differentiated offerings. However, the company's financial and liquidity constraints and recent delisting from Nasdaq present challenges to sustaining competitive advantages [S1][S2].
• Liquidity and Financial Risk: The company reported a net loss and has a current ratio of 0.3 and cash ratio of 0.03 as of September 30, 2026, indicating limited short-term liquidity which may impact its ability to meet obligations and fund operations [S2].
• Stock Market Listing Risk: Functional Brands' common stock was delisted from Nasdaq due to failure to meet minimum bid price requirements and now trades on OTC Markets, which may reduce liquidity, market price, and access to capital [Q0].
• Regulatory and Product Risk: Products are not FDA approved and the company discontinued hemp-derived products, which may affect revenue streams and expose the company to regulatory and market risks [S1].
• Convertible Preferred Stock Obligations: The company has complex convertible preferred stock arrangements with dividend obligations and redemption rights that may impose financial burdens and affect capital structure [S1].
Business trends: Expansion into digital health platforms and strategic acquisitions alongside a broad nutraceutical product portfolio.
Execution milestones: Launch of Tru2u.health platform, acquisition agreements, and product certifications aligning with industry standards.
Key risks: Financial liquidity constraints, stock delisting impacts, regulatory uncertainties, and obligations from convertible preferred stock.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Functional Brands Inc. operates in the nutraceutical supplement industry as a manufacturer and distributor of supplements across multiple categories including pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary supplements [S1].
- The company sells products primarily through pharmacies, US wholesalers, international distributors, and direct-to-consumer channels. Products are sold over the counter without prescription and are not FDA approved [S1].
- The principal business is conducted through the Kirkman division, which manufactures and markets nutraceutical products shipped throughout the United States and to 35 countries [S1].
- Functional Brands acquired HTO Nevada as a wholly-owned subsidiary in May 2023 through a share exchange agreement [S1].
- The company completed a direct listing on Nasdaq under ticker MEHA on November 5, 2025, but subsequently received a Nasdaq deficiency letter due to the stock price falling below $1.00 per share and was delisted, now trading on OTC Markets [S1, Q0].
- The company has issued Series A, B, and C Convertible Preferred Stock with detailed terms including conversion prices, dividend rates, and redemption rights [S1].
- In March 2026, the company exchanged Series A and B Convertible Preferred Stock for Series C Convertible Preferred Stock, cash, senior secured convertible promissory notes, and common stock [S1].
- Functional Brands discontinued all hemp and CBD-related product lines after December 31, 2025 [S1].
- In February 2026, the company launched Tru2u.health, a digital health platform offering peptides, GLP-1 based care with telehealth support, and clean supplements, expanding beyond traditional supplement manufacturing [S1].
- The Kirkman brand offers over 150 products including probiotics, enzymes, vitamins, multivitamins, amino acids, antioxidants, immune support, essential fatty acids, prenatal supplements, and personal care products. Kirkman products are manufactured in an FDA registered, cGMP certified facility in Oregon [S1].
- The P2i by Kirkman prenatal vitamin launched in April 2024 is certified to align with the International Federation of Gynecology and Obstetrics (FIGO) position statement on toxic chemicals and environmental contaminants, and is certified by The FORUM for low toxicity [S1].
- The company reported Q3 2026 financial results with revenue of $1,645,053, net loss of $714,455, basic and diluted EPS of -$0.01, cash and equivalents of $231,900, current assets of $2,512,446, and current liabilities of $8,317,003 as of September 30, 2026 [S2].
- Liquidity ratios as of September 30, 2026, include a current ratio of 0.3 and a cash ratio of 0.03, indicating limited short-term liquidity [S2].
- The company faces risks related to its common stock being delisted from Nasdaq and trading on OTC Markets, which may reduce liquidity and market price, and complicate capital raising [Q0].
- The company has engaged in strategic partnerships and acquisitions, including a binding letter of intent to acquire assets of BullionFX for $142.9 million [N1].
- Recent news coverage includes announcements of product launches, financial results, and strategic partnerships [N1].
Generated 2026-11-17
- S1 | 2026-03-27 | 10-K
- S2 | 2026-11-16 | 10-Q
- N1 | 2026-11-17 | www.nasdaq.com | Research Solutions Reports First Quarter Fiscal Year 2027 Results | https://www.nasdaq.com/articles/research-solutions-reports-first-quarter-fiscal-year-2027-results
- N2 | 2026-11-17 | www.nasdaq.com | Keros Therapeutics, Inc. Announces $5 million Share Repurchase Program Following $20 million Milestone | https://www.nasdaq.com/articles/keros-therapeutics-inc-announces-5-million-share-repurchase-program-following-20-million
- N3 | 2026-11-17 | www.nasdaq.com | FibroGen, Inc. Reports Third Quarter 2026 Financial Results | https://www.nasdaq.com/articles/fibrogen-inc-reports-third-quarter-2026-financial-results
- N4 | 2026-11-17 | www.nasdaq.com | Acrivon Therapeutics, Inc. Reports Third Quarter 2026 Financial Results and Business Highlights | https://www.nasdaq.com/articles/acrivon-therapeutics-inc-reports-third-quarter-2026-financial-results-and-business
- N5 | 2026-11-17 | www.nasdaq.com | Perfect Moment Ltd. Announces Executive Leadership Transitions and Loan Agreement Amendments on November 16, 2026 | https://www.nasdaq.com/articles/perfect-moment-ltd-announces-executive-leadership-transitions-and-loan-agreement
- N6 | 2026-11-17 | www.nasdaq.com | Retractable Technologies, Inc. Reports $14.1 million in Net Sales for the third quarter of 2026 | https://www.nasdaq.com/articles/retractable-technologies-inc-reports-141-million-net-sales-third-quarter-2026
- N7 | 2026-11-17 | www.nasdaq.com | Grupo Financiero Galicia S.A. Subsidiary Banco Galicia Notified of Class Action Lawsuit | https://www.nasdaq.com/articles/grupo-financiero-galicia-sa-subsidiary-banco-galicia-notified-class-action-lawsuit
- N8 | 2026-11-17 | www.nasdaq.com | Reading International, Inc. Reports Q3 2026 Total Revenues of $65.3 million and Net Income of $0.5 million | https://www.nasdaq.com/articles/reading-international-inc-reports-q3-2026-total-revenues-653-million-and-net-income-05
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


